Like Drug Safety Alliance, Inc.

announced 8/28/2012 via BNC Analysis

United Drug plc, will acquire Drug Safety Alliance, Inc.

synopsis: Irish healthcare services provider United Drug plc announced an agreement to acquire North Carolina based Drug Safety Alliance Inc. DSA is a global leader in safety and risk management services supporting pharmaceutical, biotech, medical device, consumer health and animal health organizations.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: Drug Safety Alliance, Inc.
Drug Safety Alliance, Inc. is a provider of clinical trial and post-marketing drug safety and pharmacovigilance solutions to the pharmaceutical and biotech industries. DSA manages services including case management, regulatory consulting, quality management, and a secure, validated safety database.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/5/2018 via BusinessWire

HCL Technologies Limited, acquired C3i Solutions

synopsis: HCL Technologies Limited, a leading global IT services company, announced the acquisition of C3i Solutions, a leader in multi-channel customer engagement services for the life sciences and consumer packaged goods (CPG) industries, from Merck & Co., Inc.
buyer: HCL Technologies Limited (NSEI:HCLTECH:$8,941.45)
HCL Technologies is a leading global IT services company that helps global enterprises re–imagine and transform their businesses through digital technology transformation. They focus on providing an integrated portfolio of services underlined by its Mode 1–2–3 growth strategy. "
target parent: Merck & Co., Inc.
target: C3i Solutions
C3i Solutions is multi-channel customer engagement services provider, specializing in global, high-touch consumer, patient, and end-user management. With a strategic focus on innovation, they excel at protecting their clients’ brands, while maximizing productivity and cost efficiency.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/8/2016 via PR Newswire

Highpoint Solutions, purchased Pharmacovigilance Technology Services Division from November Research Group

synopsis: HighPoint Solutions announced the acquisition of November Research Group (NRG)'s pharmacovigilance technology services division. NRG is a leading provider of pharmacovigilance system-related consulting services and an Oracle Argus Specialized partner, providing drug safety system and regulatory compliance services to Life Sciences companies.
buyer: Highpoint Solutions
HighPoint Solutions is one of the leading life sciences IT consultancies, serving over 50 clients nationwide. The company provides business consulting, system integration, and professional services including onsite industry-specialized IT staffing, off-shore resources and managed hosting. "
seller: November Research Group
The acquisition includes November Research Group (NRG)'s pharmacovigilance technology services division. NRG is the most experienced choice to help companies implement pharmacovigilance solutions, including the Oracle® Argus Safety™ Suite and other commercial adverse event reporting systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/3/2012 via BusinessWire

Dohmen Company, acquired BioSoteria, Inc.

synopsis: The Dohmen Company has acquired BioSoteria, a leading provider of drug safety and risk management services to the biopharmaceutical industry. The BioSoteria management team has experience building drug safety departments from the ground up at start-up companies and expanding pharmacovigilance capabilities for larger companies.
buyer: Dohmen Company
Dohmen is a provider of outsourced business services. Dohmen’s portfolio of service offerings includes outsourced business services to life science manufacturers through DDN, and benefit management services to life science payers through RESTAT. "
target: BioSoteria, Inc.
BioSoteria provides a broad range of drug safety services to the biopharmaceutical industry. BioSoteria helps companies manage the safety of their products with a regulatory-compliant, best-practices approach. Being a trusted pharmacovigilance service provider begins with leadership.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/23/2019 via Company Press Release

21 Partners, acquired ProductLife Group

synopsis: 21 Invest France has acquired ProductLife Group.ProductLife Group is an expert in regulatory affairs outsourced management and pharmacovigilance for the Healthcare and Life Sciences industries and more specifically for pharmaceutical laboratories.
buyer: 21 Partners
European-based 21 Partners uses reasonable efforts to obtain information from sources which it believes to be reliable, no representation or warranty is given that the information or opinions contained in this website are accurate, reliable or complete. "
target: ProductLife Group
Based in France, ProductLife Group is the global leader in regulatory and safety services, consulting, and outsourcing solutions for the life sciences industry. ProductLife Group is built on a unique and functional platform-and-geographic-hub model.
price ($mm)
rev ($mm)
$28
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 10/3/2016 via Company Press Release

Linden Capital Partners, acquired ProPharma Group

synopsis: Linden Capital Partners, a Chicago-based healthcare private equity firm, announced that it has completed its acquisition of ProPharma Group. ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
buyer: Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. "
target: ProPharma Group
ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/13/2007 via PR Newswire

Cegedim Group S.A., acquired 3ES

synopsis: Cegedim Strategic Data, leading provider of Pharmaceutical Market Research has completed its acquisition of 3ES, a CRO member of the AFCRO, specializing in Clinical Studies and post-AMM studies, notably through online tools.
buyer: Cegedim Group S.A. (ENXTPA:CGM:$512.82)
Established as the world's leading CRM provider for the life sciences industry with its Cegedim Dendrite business unit, CEGEDIM provides the world's largest pharmaceutical companies with vital support for successful Customer Relationship Management (CRM). "
target: 3ES
3ES provides multidisciplinary expertise in the medical research field. 3ES has developed their in-house software for managing online studies via Internet, and has received the ANVAR label for "innovating business".
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2015 via BusinessWire

Certara, acquired XenologiQ

synopsis: Certara, the global biosimulation technology-enabled drug development company, acquired XenologiQ, a UK-based quantitative systems pharmacology consultancy. XenologiQ's mission is to productively implement state-of-the-art modeling and simulation in medical and life sciences research.
buyer parent: Arsenal Capital Partners
buyer: Certara
Certara is a global biosimulation technology-enabled drug development company. Certara’s solutions enable superior drug development and regulatory decision-making through biosimulation, thus increasing R&D productivity and commercial value. "
target: XenologiQ
XenologiQ is a UK-based consulting company. Its mission is to productively implement state-of-the-art modeling and simulation in medical and life sciences research. Its value proposition is to achieve this via the optimal integration of experience, technical excellence and global talent.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/26/2012 via BusinessWire

Accenture, acquired Octagon Research Solutions, Inc.

synopsis: Accenture completed its acquisition of Octagon Research Solutions, a provider of clinical and regulatory information management solutions and software for the pharmaceutical industry. The acquisition enhances Accenture's existing clinical services capabilities – including clinical data management, clinical programming and safety case processing.
buyer: Accenture (ACN:$44,547.42)
Accenture is a global management consulting, technology services and outsourcing company. Accenture collaborates with clients to help them become high performance businesses and governments. "
target parent: Edison Ventures
target: Octagon Research Solutions, Inc.
Octagon Research Solutions is the world leader in clinical and regulatory information management solutions to the life sciences industry. Through an integrated suite of outsourced services, strategic consulting, and innovative technology, Octagon optimizes the entire drug development lifecycle.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via PE Hub

Catalyst Clinical Research, LLC, acquired Tri Stat

synopsis: Catalyst Clinical Research, LLC, a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies, has acquired Triangle Biostatistics, LLC (Tri Stat), a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry.
buyer parent: NovaQuest
buyer: Catalyst Clinical Research, LLC
Catalyst Clinical Research is a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company assists clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions. "
target: Tri Stat
Triangle Biostatistics (Tri Stat) is a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry. Tri Stat provides strong statistical consulting and programming support utilizing the latest computing technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via Company Press Release

Advarra, acquired Kinetiq

synopsis: Advarra, the premier provider of institutional review board (IRB) and research quality and compliance consulting services, acquired Quorum’s research and technology consulting division, Kinetiq. Kinetiq delivers innovative solutions for human subject protection and compliance in clinical research.
buyer parent: Linden Capital Partners
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Quorum Review IRB
target: Kinetiq
Kinetiq is a consulting and technology division of Quorum Review IRB that delivers innovative solutions for human subject protection and compliance in clinical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2014 via BusinessWire

Perficient, Inc., acquired BioPharm Systems, Inc.

synopsis: Perficient, Inc., a leading information technology consulting firm serving Global 2000 and other large enterprise customers throughout North America, announced it has acquired BioPharm Systems, Inc., a $15 million annual services revenue business and information technology consulting firm focused on the life sciences industry.
buyer: Perficient, Inc. (PRFT:$577.27)
Perficient is a leading information technology consulting firm serving Global 2000 and enterprise customers throughout North America. Perficient’s professionals serve clients from a network of offices across North America and three offshore locations, in Eastern Europe, India, and China. "
target: BioPharm Systems, Inc.
BioPharm Systems is a global IT consulting and managed services provider that focuses on the life sciences industry. BioPharm Systems has extensive experience in the implementation, integration, migration, upgrade, and hosting of clinical trial management, drug safety and pharmacovigilance and more.
price ($mm)
$18
rev ($mm)
$15
EBITDA ($mm)
EV / rev
1.2x
EV / EBITDA
closed 3/12/2014 via PR Web

d-Wise Technologies Inc., acquired Dootsonic Ltd.

synopsis: d-Wise Technologies, UK Ltd., announced that it has entered into an agreement to acquire Dootsonic Ltd., a privately-owned technology organization specializing in the support of the management, analysis and reporting of data from clinical trials.
buyer: d-Wise Technologies Inc.
d-Wise is a technology leader with the expertise to empower world-class life science and healthcare organizations to resolve their business optimization challenges, helping them rapidly harness and leverage data, systems and processes to gain competitive advantage. "
target: Dootsonic Ltd.
Dootsonic is a specialty technology consulting company, focused primarily on biometrics technology and process, providing high quality services for their clients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/27/2013 via Company Press Release

PPD, Inc., acquired Acurian, Inc.

synopsis: Pharmaceutical Product Development, LLC, a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services, announced it has acquired Acurian, a leading full-service provider of clinical trial patient enrollment and retention solutions for the life sciences industry.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: Acurian, Inc.
Acurian, Inc. provides solutions needed to recruit, enroll, and retain patients for clinical trials. It offers recruitment feasibility, site identification and selection, patient recruitment and retention, and cancer solutions; and formulates a plan based on historical performance data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/18/2012 via BusinessWire

Adjility Health will be merged with Alliance Life Sciences Consulting Group, Inc,

synopsis: Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, and Adjility Consulting, a consulting firm specializing in management consulting and analytic solutions for clinical operations and the global market access, pricing and reimbursement space, announced that the two companies will merge.
buyer: Alliance Life Sciences Consulting Group, Inc
Alliance Life Sciences Consulting Group employs more than 175 professionals who collectively understand the business challenges of the Life Sciences industry and offer solutions for Sales & Marketing, Managed Care & Government Contracting, Commercial Operations, Information Management and Analytics."
target: Adjility Health
Adjility Health is dedicated to helping healthcare companies improve their operations through the use of strategic consulting services and very industry domain-specific analytic, forecasting, predictive trending and other data insight tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2017 via BNC Analysis

Exact Sciences, acquired Sampleminded

synopsis: Exact Sciences, a molecular diagnostics company, acquired Sampleminded. Sampleminded is an information technology company that develops software for use in clinical trials and for research and diagnostics. Sampleminded offers highly-configurable tools to manage specimen tracking and chain of custody for multi-study, multi-site clinical trials.
buyer: Exact Sciences (EXAS:$213.82)
Exact Sciences is a molecular diagnostics company focused on colorectal cancer. Exact Sciences develops diagnostic tests for several types of cancer. Its flagship product is Cologuard, a stool-based DNA test for colorectal cancer. "
target: Sampleminded
Sampleminded is an information technology company that develops software for use in clinical trials and for research and diagnostics. Sampleminded offers low-cost, highly-configurable tools to manage specimen tracking and chain of custody for multi-study, multi-site clinical trials.
price ($mm)
$7.62
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/16/2016 via PR Newswire

Indegene Lifesystems Pvt Ltd., acquired Wincere, Inc.

synopsis: Indegene, a global healthcare solutions provider, announced the acquisition of Wincere Inc. Wincere is a leading clinical data management and clinical and statistical programming solutions provider located on the West Coast in Silicon Valley, CA. Wincere is deeply engaged with clinical R&D needs of many emerging biopharma companies.
buyer: Indegene Lifesystems Pvt Ltd.
Indegene enables global healthcare organizations to address complex challenges by seamlessly integrating analytics, technology, operations and medical expertise and drives better health and business outcomes. "
target: Wincere, Inc.
Wincere provides smarter clinical research services across all clinical trial phases by using its patent-pending technology to support clinical trial startup, conduct, and submission activities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/22/2020 via BusinessWire

Diamond Pharma Services, acquired PharmaCentral

synopsis: Diamond Pharma Services, a leading technical services and regulatory affairs consulting group, announced its pharmacovigilance division, Diamond PV Services, has acquired PharmaCentral, an innovative pharmacovigilance services and medical affairs business based in Dublin, Ireland.
buyer: Diamond Pharma Services
Diamond Pharma Services provides Regulatory Affairs, Pharmacovigilance and Compliance & Quality services to support pharmaceutical and biotechnology companies in obtaining and maintaining medicinal product licences throughout all stages of a product’s life cycle. "
target: PharmaCentral
PharmaCentral is an innovative pharmacovigilance services and medical affairs business based in Dublin, Ireland. They offer a wide range of pharmacovigilance consultancy services, based on a wealth of experience in pharmacovigilance and medical affairs in both pharma and CRO environments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/4/2018 via Company Press Release

Ashfield Commercial & Medical Services, acquired SmartAnalyst, Inc.

synopsis: UDG Healthcare plc, a leading international healthcare services provider, is pleased to announce the acquisition of SmartAnalyst, a New York-based strategic commercialisation consulting and analytics business. The business will become part of Ashfield Communications.
buyer parent: UDG Healthcare plc
buyer: Ashfield Commercial & Medical Services
Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry. They provide field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services. "
target: SmartAnalyst, Inc.
SmartAnalyst is a US-based strategic consulting and analytics business focused on the pharmaceutical and biotech sector. SmartAnalyst provides strategic consulting services to pharmaceutical and biotech companies to support disease, asset, and portfolio level decisions.
price ($mm)[EV]
$18 [$12]
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/21/2015 via PR Newswire

BioClinica, Inc., acquired Synowledge

synopsis: BioClinica, Inc., a specialty clinical trials services and technology provider, announced that it has acquired Synowledge to expand into the drug safety and regulatory business process outsourcing market. Synowledge specializes in pharmacovigilance, regulatory affairs and information technology services to support biopharmaceutical companies.
buyer parent: JLL Partners
buyer: BioClinica, Inc.
BioClinica is a specialty clinical trials services provider that improves the development of new medical therapies by delivering expertise and technologies that enhance clinical research data and analytics, worldwide. "
target: Synowledge
Synowledge is a specialized drug safety, regulatory affairs and IT services provider that assists and enables small, medium and large life sciences organizations to satisfy their global regulatory requirements.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/28/2012 via BNC Analysis

United Drug plc, will acquire Drug Safety Alliance, Inc.

synopsis: Irish healthcare services provider United Drug plc announced an agreement to acquire North Carolina based Drug Safety Alliance Inc. DSA is a global leader in safety and risk management services supporting pharmaceutical, biotech, medical device, consumer health and animal health organizations.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: Drug Safety Alliance, Inc.
Drug Safety Alliance, Inc. is a provider of clinical trial and post-marketing drug safety and pharmacovigilance solutions to the pharmaceutical and biotech industries. DSA manages services including case management, regulatory consulting, quality management, and a secure, validated safety database.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/26/2019 via Company Press Release

UDG Healthcare plc, acquired Canale Communications

synopsis: UDG Healthcare, an Ireland-based global leader in healthcare advisory, communications, commercial, clinical and packaging services, has acquired Canale Communications, a strategic communications and creative firm exclusively serving the life science and healthcare industries.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
Headquartered in Ireland, UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries. "
target: Canale Communications
Canale Communications is a strategic communications and creative firm exclusively serving the life science and healthcare industries. It has worked with more than 300 biotech, health tech, and pharmaceutical companies at virtually every stage of development.
price ($mm)
$20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via Company Press Release

UDG Healthcare plc, acquired Putnam Associates

synopsis: UDG Healthcare plc, a leading international healthcare services provider, announces the acquisition of Putnam Associates, a company that provides strategic advice based on sophisticated and robust analytics to biopharmaceutical, diagnostics, and medical device clients.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries. "
target: Putnam Associates
Putnam Associates serves global biopharmaceutical, diagnostics, and medical device clients, along with private equity and venture capital clients, providing world class strategic advice based on sophisticated, robust analytics.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/4/2018 via Company Press Release

Ashfield Commercial & Medical Services, acquired Create NYC

synopsis: UDG Healthcare plc, a leading international healthcare services provider, is pleased to announce the acquisition of Create NYC, a New York-based disruptive creative communications agency. The business will become part of UDG's Ashfield Communications, a global leader in commercialisation services for the pharmaceutical and healthcare industry.
buyer parent: UDG Healthcare plc
buyer: Ashfield Commercial & Medical Services
Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry. They provide field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services. "
target: Create NYC
Create NYC is an innovative New York-based healthcare creative communications agency, offering the tactical execution of sales and marketing materials for its international pharmaceutical clients.
price ($mm)
$58
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/4/2018 via Company Press Release

Ashfield Commercial & Medical Services, acquired SmartAnalyst, Inc.

synopsis: UDG Healthcare plc, a leading international healthcare services provider, is pleased to announce the acquisition of SmartAnalyst, a New York-based strategic commercialisation consulting and analytics business. The business will become part of Ashfield Communications.
buyer parent: UDG Healthcare plc
buyer: Ashfield Commercial & Medical Services
Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry. They provide field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services. "
target: SmartAnalyst, Inc.
SmartAnalyst is a US-based strategic consulting and analytics business focused on the pharmaceutical and biotech sector. SmartAnalyst provides strategic consulting services to pharmaceutical and biotech companies to support disease, asset, and portfolio level decisions.
price ($mm)[EV]
$18 [$12]
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/20/2017 via BNC Analysis

UDG Healthcare plc, acquired MicroMass Communications, Inc.

synopsis: UDG Healthcare, an international healthcare services provider, announced the acquisition of MicroMass Communications, a U.S.-based healthcare communications agency specializing in behavioural change.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
UDG Healthcare plc is a leading international partner of choice delivering clinical, commercial, communication and packaging services to the healthcare industry, employing 8,000 with operations in 23 countries and delivering services in over 50 countries. "
target parent: Periscope Equity
target: MicroMass Communications, Inc.
MicroMass Communications is a healthcare marketing agency specializing in digital, relationship marketing, and non-personal promotion. Their unique expertise in human health behavior allows them to create highly effective solutions for patients and health care providers.
price ($mm)
$64
rev ($mm)
$23
EBITDA ($mm)
EV / rev
3.3x
EV / EBITDA
closed 5/19/2016 via Company Press Release

Ashfield Commercial & Medical Services, acquired Pegasus Public Relations Ltd

synopsis: Pegasus, one of the most successful integrated healthcare communications consultancies in the UK, announced it has been acquired by UDG Healthcare plc, an international provider of outsourced healthcare services. Pegasus joins Ashfield Healthcare Communications, which is part of UDG Healthcare’s Ashfield Commercial and Medical Services Division.
buyer parent: UDG Healthcare plc
buyer: Ashfield Commercial & Medical Services
Ashfield is a global leader in providing outsourced healthcare services to pharmaceutical, device and biotech companies. Ashfield provides contract sales teams, customer service reps, remote detailing, nurse educators, medical information, healthcare communications, and other services. "
target: Pegasus Public Relations Ltd
Pegasus specialises in helping private and public sector organisations communicate healthy messages through integrated communications programmes. Pegasus has an award-winning track record of creating and implementing campaigns that inspire behavior change.
price ($mm)
$15
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/27/2014 via BNC Analysis

UDG Healthcare plc, acquired KnowledgePoint360

synopsis: UDG Healthcare plc, a leading international provider of healthcare services, announced that it has agreed to acquire the healthcare communications business of KnowledgePoint360. The deal, agreed at a total cash consideration of $144 million. KnowledgPoint360 provides a broad range of medical communications services.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
UDG Healthcare plc, together with its subsidiaries provides supply chain, packaging, medical, regulatory, and sales and marketing services to healthcare manufacturers and pharmacies operating in the Republic of Ireland, the United Kingdom, North America, and continental Europe. "
target parent: ABRY Partners, LLC
target: KnowledgePoint360
KnowledgPoint360 provides a broad range of medical communications services, including medical education, publication support, live educational meetings, scientific content development, exhibit design, digital solutions, training, workflow and compliance solutions.
price ($mm)
$144
rev ($mm)
$106
EBITDA ($mm)
$20
EV / rev
1.4x
EV / EBITDA
7.2x
announced 8/28/2012 via BNC Analysis

United Drug plc, will acquire Drug Safety Alliance, Inc.

synopsis: Irish healthcare services provider United Drug plc announced an agreement to acquire North Carolina based Drug Safety Alliance Inc. DSA is a global leader in safety and risk management services supporting pharmaceutical, biotech, medical device, consumer health and animal health organizations.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: Drug Safety Alliance, Inc.
Drug Safety Alliance, Inc. is a provider of clinical trial and post-marketing drug safety and pharmacovigilance solutions to the pharmaceutical and biotech industries. DSA manages services including case management, regulatory consulting, quality management, and a secure, validated safety database.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/28/2012 via BNC Analysis

United Drug plc, will acquire Synopia RX, LLC

synopsis: Irish healthcare services provider United Drug plc, announced an agreement to acquire Synopia RX LLC. SynopiaRx consults with BioTech and Pharmaceutical companies as well as investment organizations to deliver market intelligence, strategies and account management.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: Synopia RX, LLC
SynopiaRx engages with companies in the BioTech and Pharmaceutical industry to optimize their commercialization of medicines in the managed care marketplace.
price ($mm)
$3.20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/26/2012 via BNC Analysis

United Drug plc, acquired Watermeadow

synopsis: United Drug plc (UD) announced that it has acquired the entire issued share capital of Watermeadow Medical Ltd and Watermeadow Medical Consulting Inc for a total consideration of up to £13m. Watermeadow is a healthcare communications and consultancy agency headquartered in the UK with offices also in the US.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: Watermeadow
Watermeadow is a healthcare communications and consultancy agency headquartered in the UK with offices also in the US. It provides services to global pharmaceutical companies, including medical writing and preparation of promotional and educational materials typically for products pre-launch.
price ($mm)
$9.35
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2010 via Company Press Release

United Drug plc, acquired World Events Group, Ltd.

synopsis: United Drug, plc has acquired WorldEvents® Group, the global group of event management companies headed by WorldEvents® Group Limited. WorldEvents® is one of the UK’s top five event management businesses, specialising in the healthcare/pharmaceutical sector.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: World Events Group, Ltd.
WorldEvents® is an international event agency. WorldEvents® is ranked in the top ten event management agencies in Europe and has won numerous industry awards for the work it has conducted for its clients.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2010 via BNC Analysis

United Drug plc, acquired InforMed Direct

synopsis: United Drug Plc, an Ireland-based healthcare services provider, has acquired the entire share capital of InforMed Direct Plc, a UK-based healthcare communications and market research agency, for a consideration of GBP11.4 million in cash.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: InforMed Direct
InforMed offers healthcare communications at every stage of the product lifecycle – from development and consultancy to tactical delivery. Its market research and business analysis division delivers quant and qual research, as well as forecasting and market simulation models.
price ($mm)
$18
rev ($mm)
$16
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
closed 7/29/2015 via PE Hub

Tailwind Capital Partners, acquired National HME

synopsis: Tailwind Capital, a leading middle market private equity firm investing in growth-oriented companies in healthcare, business and communications services, announced the acquisition of National HME, Inc. (“NHME”). NHME is the largest provider of outsourced medical equipment management solutions to the hospice market.
buyer: Tailwind Capital Partners
Tailwind Capital Partners is an independent private equity firm focused on investments in healthcare, media/communications and business services companies. "
target: National HME
National HME, Inc. ("NHME") is the largest provider of outsourced medical equipment management solutions to the hospice market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/2/2004 via BusinessWire

McKesson Corporation, acquired Moore Medical Corporation

synopsis: McKesson Corporation (NYSE:MCK), the world's leading healthcare services company and the largest distributor of medical surgical supplies and pharmaceuticals to the alternate site marketplace, today announced that it has completed the acquisition of Moore Medical Corporation (AMEX:MMD) of New Britain, Conn.
buyer: McKesson Corporation (MCK:$214,319.00)
McKesson Corporation, is a healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care. "
target: Moore Medical Corporation
Moore Medical Corp. is an Internet-enabled multi-channel marketer and distributor of medical, surgical and pharmaceutical products to over 100,000 healthcare practices and facilities in non-hospital settings nationwide, including physicians, emergency medical technicians, schools, correctional inst
price ($mm)
$43
rev ($mm)
$143
EBITDA ($mm)
$2
EV / rev
0.3x
EV / EBITDA
20.2x
closed 1/20/2016 via BusinessWire

ASP Global, acquired InHome Medical Solutions

synopsis: ASP Global, an industry leader in global sourcing of hospital medical supplies, has acquired Jacksonville, FL based InHome Medical Solutions, a leading wholesale medical products distribution company serving physicians, home health and hospice providers. InHome's technology platform enables clinicians to easily order and track supplies online.
buyer: ASP Global
ASP Global is a leading global sourcing agent/wholesaler of medical supplies with a proven track record. Their long-standing relationships with 120+ factories enable them to deliver high quality products at factory pricing directly to their clients. "
target: InHome Medical Solutions
InHome Medical Solutions is a leading wholesale medical products distribution company serving physicians, home health and hospice providers. InHome delivers a comprehensive range of diabetic, respiratory, urological, incontinence, wound care, ostomy, and home medical equipment products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/10/2019 via PR Newswire

PNC Riverarch Capital, acquired Safco Dental Supply

synopsis: PNC Riverarch Capital, a middle-market private equity firm which invests in privately held companies, has acquired Safco Dental Supply, an online distributor of dental supplies to independent dental practitioners.
buyer parent: The PNC Financial Services Group
buyer: PNC Riverarch Capital
PNC Riverarch Capital is a middle-market private equity firm that invests in companies headquartered throughout North America. They work closely with their portfolio company teams to maximize their growth potential while preserving their culture and legacy. "
target: Safco Dental Supply
Safco Dental Supply is an online distributor of dental supplies to independent dental practitioners. They are known for offering top quality products at prices significantly lower than other dental supply dealers.
price ($mm)
$175
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Drug Safety Alliance, Inc.


read more

Drug Safety Alliance, Inc.

C3i Solutions

November Research Group

BioSoteria, Inc.

ProductLife Group

ProPharma Group

3ES

XenologiQ

Octagon Research Solutions, Inc.

Tri Stat

Kinetiq

BioPharm Systems, Inc.

Dootsonic Ltd.

Acurian, Inc.

Adjility Health

Sampleminded

Wincere, Inc.

PharmaCentral

SmartAnalyst, Inc.

Synowledge

read more

Drug Safety Alliance, Inc.

read more

Canale Communications

Putnam Associates

Create NYC

SmartAnalyst, Inc.

MicroMass Communications, Inc.

Pegasus Public Relations Ltd

KnowledgePoint360

Drug Safety Alliance, Inc.

Synopia RX, LLC

Watermeadow

World Events Group, Ltd.

InforMed Direct

read more

National HME

Moore Medical Corporation

InHome Medical Solutions

Safco Dental Supply

TGaS Advisors, LLC

Geography
Matching Companies
Ticker: MCK
 
 
 
 
 
 
 
 
McKesson Corporation
McKesson Corporation
McKesson Corporation is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care.
year
2019
rev ($mm)
$214,319.00
EBITDA ($mm)
$4,229.00
EBIT ($mm)
$3,280.00
Net Income ($mm)
$34.00
Employees
70000
  • drill down
  • watch
Ticker: HSIC
 
 
 
 
 
 
 
 
Henry Schein, Inc.
Henry Schein, Inc.
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites.
year
2019
rev ($mm)
$13,288.81
EBITDA ($mm)
$1,117.53
EBIT ($mm)
$905.38
Net Income ($mm)
$505.45
Employees
19000
  • drill down
  • watch
Ticker: LSE:UDG
 
 
 
 
 
 
 
 
UDG Healthcare plc
UDG Healthcare plc
UDG Healthcare plc specialises in supply chain, packaging, medical, regulatory, and sales and marketing services. They provide innovative, outsourced services that deliver outstanding results for healthcare companies and enable them to bring their products quickly to market.
year
2019
rev ($mm)
$1,298.52
EBITDA ($mm)
$178.30
EBIT ($mm)
$122.78
Net Income ($mm)
$57.45
Employees
7790
  • drill down
  • watch
Ticker: PDCO
 
 
 
 
 
 
 
 
Patterson Companies, Inc.
Patterson Companies, Inc.
Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet veterinarian and rehabilitation supply markets. As Patterson's largest business, Patterson Dental provides a virtually complete range of consumable dental products, equipment and software.
year
2012
rev ($mm)
$3,535.66
EBITDA ($mm)
$400.22
EBIT ($mm)
$358.01
Net Income ($mm)
$212.82
Employees
7059
  • drill down
  • watch
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch